| The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas E Binda, A Visioli, F Giani, G Lamorte, M Copetti, KL Pitter, JT Huse, ... Cancer cell 22 (6), 765-780, 2012 | 267 | 2012 |
| Human neural stem cell transplantation in ALS: initial results from a phase I trial L Mazzini, M Gelati, DC Profico, G Sgaravizzi, M Projetti Pensi, G Muzi, ... Journal of translational medicine 13, 1-16, 2015 | 212 | 2015 |
| Wnt5a drives an invasive phenotype in human glioblastoma stem-like cells E Binda, A Visioli, F Giani, N Trivieri, O Palumbo, S Restelli, F Dezi, ... Cancer research 77 (4), 996-1007, 2017 | 108 | 2017 |
| Results from phase I clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: a long-term outcome L Mazzini, M Gelati, DC Profico, G Sorarù, D Ferrari, M Copetti, G Muzi, ... Stem Cells Translational Medicine 8 (9), 887-897, 2019 | 95 | 2019 |
| Engineered ferritin nanoparticles for the bioluminescence tracking of nanodrug delivery in cancer M Bellini, B Riva, V Tinelli, MA Rizzuto, L Salvioni, M Colombo, ... Small 16 (39), 2001450, 2020 | 41 | 2020 |
| Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats C Zalfa, L Rota Nodari, E Vacchi, M Gelati, D Profico, M Boido, E Binda, ... Cell Death & Disease 10 (5), 345, 2019 | 36 | 2019 |
| Heterogeneity of cancer-initiating cells within glioblastoma E Binda, A Visioli, B Reynolds, AL Vescovi Front Biosci (Schol Ed) 4, 1235-1248, 2012 | 33 | 2012 |
| BRAFV600E mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies N Trivieri, R Pracella, MG Cariglia, C Panebianco, P Parrella, A Visioli, ... Journal of Experimental & Clinical Cancer Research 39, 1-16, 2020 | 25 | 2020 |
| Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies A Visioli, F Giani, N Trivieri, R Pracella, E Miccinilli, MG Cariglia, ... EBioMedicine 44, 346-360, 2019 | 16 | 2019 |
| Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial EM Bos, E Binda, ISC Verploegh, E Wembacher, D Hoefnagel, ... Molecular cancer 22 (1), 129, 2023 | 14 | 2023 |
| Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental … N Trivieri, A Visioli, G Mencarelli, MG Cariglia, L Marongiu, R Pracella, ... Journal of Experimental & Clinical Cancer Research 41 (1), 139, 2022 | 6 | 2022 |
| Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies A Visioli, N Trivieri, G Mencarelli, F Giani, M Copetti, O Palumbo, ... Journal of Experimental & Clinical Cancer Research 42 (1), 244, 2023 | 3 | 2023 |
| A functional role of Ephrin type-B receptor 6 (EPHB6) in T-cell acute lymphoblastic leukemia M Colucci, N Trivieri, G Mencarelli, E De Santis, F Sansico, F Tamiro, ... Biomarker Research 11 (1), 92, 2023 | 2 | 2023 |
| A LOCAL DELIVERY OF HRBMP4 AS AN ANTICANCER THERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA: A FIRST-IN-HUMAN PHASE 1 DOSE ESCALATION TRIAL EM Bos, E Binda, IS Verploegh, E Wembacher, D Hoefnagel, RK Balvers, ... NEURO-ONCOLOGY 26, V21-V21, 2024 | | 2024 |
| Drug Delivery in an Orthotopic Tumor Stem Cell-Based Model of Human Glioblastoma E Binda, A Visioli, N Trivieri, AL Vescovi Brain Tumor Stem Cells: Methods and Protocols, 197-205, 2019 | | 2019 |
| Pro-Differentiation Anticancer Therapy Using Local Delivery of hrBMP4 in Patients with Recurrent Glioblastoma: A First-in-Human Phase 1 Dose Escalation Trial EM Bos, E Binda, ISC Verploegh, E Wembacher-Schroeder, D Hoefnagel, ... | | |
